---
figid: PMC8155723__fphar-12-655114-g003
figtitle: Pathogenesis and Function of Interleukin-35 in Rheumatoid Arthritis
organisms:
- Mus musculus
- Rattus norvegicus
- gut metagenome
- Bacteroides fragilis
- human gut metagenome
- segmented filamentous bacterium
- Homo sapiens
- Human gammaherpesvirus 4
organisms_ner:
- Rattus norvegicus
- Mus musculus
- Homo sapiens
pmcid: PMC8155723
filename: fphar-12-655114-g003.jpg
figlink: /pmc/articles/PMC8155723/figure/F3/
number: F3
caption: The regulatory mechanism of IL- 35 in RA. IL-35 is secreted by Treg via JAK/STAT
  signaling pathway. Production of IL-35 and IL-10 triggers Th17 differentiation.
  In turn, IL-35 which produced by Treg cells, enhances IL-35 expression. Moreover,
  IL-35 also inhibits Ang2/Tie2 via NF-κB, and with the suppression of VEGF, VEGFR,
  Tie2, it causes angiogenesis. IL-35 also stimulates OPG secretion and competitively
  binded RANKL with OPG by inhibiting Wnt/β-catenin signaling pathway, and it inhibits
  bone destruction in the course of RA. Thus, IL-35 acts as an anti-inflammatory factor
  participating in RA via various pathways.
papertitle: Pathogenesis and Function of Interleukin-35 in Rheumatoid Arthritis.
reftext: Pan Lin Xin, et al. Front Pharmacol. 2021;12:655114.
year: '2021'
doi: 10.3389/fphar.2021.655114
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: rheumatoid arthritis | IL-35 | IL-12 family | treg | Th17 | article highlights
automl_pathway: 0.9593051
figid_alias: PMC8155723__F3
figtype: Figure
redirect_from: /figures/PMC8155723__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8155723__fphar-12-655114-g003.html
  '@type': Dataset
  description: The regulatory mechanism of IL- 35 in RA. IL-35 is secreted by Treg
    via JAK/STAT signaling pathway. Production of IL-35 and IL-10 triggers Th17 differentiation.
    In turn, IL-35 which produced by Treg cells, enhances IL-35 expression. Moreover,
    IL-35 also inhibits Ang2/Tie2 via NF-κB, and with the suppression of VEGF, VEGFR,
    Tie2, it causes angiogenesis. IL-35 also stimulates OPG secretion and competitively
    binded RANKL with OPG by inhibiting Wnt/β-catenin signaling pathway, and it inhibits
    bone destruction in the course of RA. Thus, IL-35 acts as an anti-inflammatory
    factor participating in RA via various pathways.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Il10
  - Anxa1
  - Cdk5r1
  - Ebi3
  - Il12rb2
  - Jak1
  - Jak2
  - Stat1
  - Stat4
  - Nfkb1
  - Tnfrsf11b
  - Mmp23
  - Wnt2
  - Dkk1
  - Vegfa
  - Tnfsf11
  - Il12a
  - Upk3b
  - Gchfr
  - IL10
  - RETN
  - FCN2
  - GCHFR
  - IL12A
  - CDK5R1
  - UPK3B
  - EBI3
  - IL12RB2
  - JAK1
  - JAK2
  - STAT1
  - STAT4
  - NFKB1
  - BTF3P11
  - TNFRSF11B
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - DKK1
  - KDR
  - FLT1
  - FLT4
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - TNFSF11
---
